Induction of polysaccharide vaccine responses in the young by interleukin-7
白细胞介素7诱导年轻人多糖疫苗反应
基本信息
- 批准号:8638380
- 负责人:
- 金额:$ 7.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-01 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAntibodiesAntibody FormationAntigensB-Lymphocyte SubsetsB-LymphocytesBacteriaBinding ProteinsBorreliaCD34 geneCell CountCellsCharacteristicsChildCloaca ChamberCommunicable DiseasesComplement Factor HDataDevelopmentDextransEncapsulatedEnterobacter cloacaeExhibitsFicollFrequenciesHematopoietic stem cellsHumanHumoral ImmunitiesImmune responseImmune systemImmunityImmunizationImpairmentIndividualInfantInfectionInterleukin-7KineticsLeadLifeLymphocyteMature B-LymphocyteMeasuresMemory B-LymphocyteMolecularMorbidity - disease rateMusNeonatalPhenotypePlasma CellsPlayPolysaccharidesReceptors, Antigen, B-CellRoleSalmonella typhiSignal TransductionStreptococcus pneumoniaeStromal CellsSupplementationSurface AntigensT-LymphocyteTransgenic MiceTransgenic OrganismsTranslatingUmbilical Cord BloodVaccinationVaccinesacquired immunodeficiencybasedextraninfant morbidity/mortalitymortalitymouse modelnovelnovel strategiespathogenpublic health relevancereconstitutionresponse
项目摘要
Antibody responses to classical T cell-independent (TI) antigens such as bacterial capsular polysaccharides
are highly protective, and play a critical role in controlling a number of clinically important infections. For
reasons that remain poorly understood young children cannot mount antibody responses to TI antigens and as
a consequence are much more prone to suffer from life-threatening infections, particularly from encapsulated
bacterial pathogens. As with young children, young mice respond poorly to polysaccharide antigens, while
human adults as well as adult mice can mount a very efficient response to polysaccharide antigens. B1b
lymphocytes are a subset of mature B cells that increases in number in response to a variety of TI antigens
including type 3 polysaccharide of Streptococcus pneumoniae (PPS3), ¿1,3 dextran of Enterobacter cloacae,
Vi polysaccharide of Salmonella typhi and Factor H binding protein A, a surface antigen of Borrelia hermsii.
Furthermore, these cells generate rapid primary antibody as well as long-lasting memory B cell responses.
Despite having B1b cells, young mice are impaired in responding to polysaccharide antigens, suggesting that
B cells in the young are distinct from those in adults. Since B lymphopoeisis early in life is largely IL-7-
independent, while in adults it is IL-7-dependent, we hypothesize that B cells developed in the presence of IL-7
are required for generating anti-polysaccharide antibody responses. In support of this, we found that despite
having B1b cells, young wildtype, adult IL-7-/- or adult IL-7R¿-/- mice are severely impaired in responding to
classical TI antigens such as 4-hydroxy-3-nitrophenyl-acetyl-Ficoll (NP-Ficoll), bacterial dextran and PPS
vaccine, and do not survive S. pneumoniae challenge after PPS immunization. Furthermore, we found that
transgenic expression of IL-7 promotes the anti-PPS response in young and confers protective immunity to S.
pneumoniae. These data support the hypothesis that IL-7-dependent B cells play a crucial role in generating TI
humoral immunity. To translate these findings to human infants we have utilized neonatal NOD/SCID/¿cnull
mice engrafted with human umbilical cord blood CD34+ hematopoietic stem cells to create a "Human Immune
System" mouse (HISmouse) model. We have found that these HISmice generate several subsets of B cells
including B1 cells and the majority of them exhibit an immature B cell phenotype. Moreover, just as young
children, HISmice responded poorly to PPS and sub-optimally to B. hermsii. Since IL-7 is produced mainly by
non-hematopoietic stromal cells, and murine IL-7 is poor stimulator of human lymphocyte development, this
impairment could be due to the lack of human IL-7-driven B cells in HISmice. In support of this we found that
supplementation of HISmice with human IL-7 dramatically increases humoral responses to B. hermsii. The
aims outlined in this proposal seek to: 1) determine whether IL-7 increases the number of polysaccharide-
specific B1b cells; and 2) determine whether the B1b cells generated in the presence or absence of IL-7 are
qualitatively different.
对经典 T 细胞非依赖性 (TI) 抗原(例如细菌荚膜多糖)的抗体反应
具有高度保护性,在控制许多临床重要感染方面发挥着关键作用。为了
幼儿无法对 TI 抗原产生抗体反应的原因仍知之甚少,并且
结果是更容易遭受危及生命的感染,特别是来自包膜的感染
细菌病原体。与幼儿一样,年幼的小鼠对多糖抗原的反应较差,而
成人以及成年小鼠可以对多糖抗原产生非常有效的反应。 B1b
淋巴细胞是成熟 B 细胞的一个子集,其数量会随着各种 TI 抗原的反应而增加
包括肺炎链球菌3型多糖(PPS3)、阴沟肠杆菌的1,3葡聚糖、
Vi 伤寒沙门氏菌的多糖和H因子结合蛋白A,赫氏疏螺旋体的表面抗原。
此外,这些细胞可产生快速的一抗以及持久的记忆 B 细胞反应。
尽管有 B1b 细胞,但年轻小鼠对多糖抗原的反应受损,这表明
年轻人的 B 细胞与成人的不同。由于生命早期的 B 淋巴细胞生成主要是 IL-7-
独立的,而在成人中它是 IL-7 依赖性的,我们假设 B 细胞在 IL-7 存在的情况下发育
是产生抗多糖抗体反应所必需的。为了支持这一点,我们发现尽管
具有 B1b 细胞的年轻野生型小鼠、成年 IL-7-/- 或成年 IL-7R¿-/- 小鼠对 B1b 细胞的反应严重受损
经典 TI 抗原,例如 4-羟基-3-硝基苯基-乙酰基-聚蔗糖 (NP-Ficoll)、细菌葡聚糖和 PPS
疫苗,并且在 PPS 免疫后不能存活于肺炎链球菌攻击。此外,我们发现
IL-7 的转基因表达可促进年轻人的抗 PPS 反应,并赋予对金黄色葡萄球菌的保护性免疫力。
肺炎杆菌。这些数据支持这样的假设:IL-7 依赖性 B 细胞在产生 TI 中发挥着至关重要的作用
体液免疫。为了将这些发现转化为人类婴儿,我们利用了新生儿 NOD/SCID/¿cnull
小鼠移植人脐带血CD34+造血干细胞,打造“人类免疫细胞”
System”小鼠(HISmouse)模型。我们发现这些HISmice产生了几个B细胞亚群
包括 B1 细胞,其中大多数表现出不成熟的 B 细胞表型。而且,同样年轻
对于儿童,HISmice 对 PPS 的反应较差,对 B. Hermsii 的反应也不佳。由于 IL-7 主要由
非造血基质细胞,而鼠 IL-7 对人类淋巴细胞发育的刺激作用较差,因此
损伤可能是由于 HISmice 中缺乏人类 IL-7 驱动的 B 细胞所致。为了支持这一点,我们发现
给 HISmice 补充人 IL-7 可以显着增加对赫氏芽孢杆菌的体液反应。这
本提案概述的目标旨在:1) 确定 IL-7 是否增加多糖的数量
特定的 B1b 细胞; 2) 确定在存在或不存在 IL-7 的情况下生成的 B1b 细胞是否是
质不同。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KISHORE R ALUGUPALLI其他文献
KISHORE R ALUGUPALLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KISHORE R ALUGUPALLI', 18)}}的其他基金
A System to Study Salmonella Typhi Infection and Immunity
研究伤寒沙门氏菌感染和免疫的系统
- 批准号:
10361479 - 财政年份:2021
- 资助金额:
$ 7.75万 - 项目类别:
A System to Study Salmonella Typhi Infection and Immunity
研究伤寒沙门氏菌感染和免疫的系统
- 批准号:
10195207 - 财政年份:2021
- 资助金额:
$ 7.75万 - 项目类别:
Stem cell origins of human fetal/neonatal B cell subsets
人类胎儿/新生儿 B 细胞亚群的干细胞起源
- 批准号:
10159198 - 财政年份:2020
- 资助金额:
$ 7.75万 - 项目类别:
Regulation of bacterial polysaccharide-specific B cell responses
细菌多糖特异性 B 细胞反应的调节
- 批准号:
9329963 - 财政年份:2016
- 资助金额:
$ 7.75万 - 项目类别:
B1 cell-mediated immunity in Human Immune System mice
人类免疫系统小鼠中 B1 细胞介导的免疫
- 批准号:
8856488 - 财政年份:2014
- 资助金额:
$ 7.75万 - 项目类别:
Role of BAFFR in antigen-specific B1b cell persistence
BAFFR 在抗原特异性 B1b 细胞持久性中的作用
- 批准号:
8623197 - 财政年份:2014
- 资助金额:
$ 7.75万 - 项目类别:
B1 cell-mediated immunity in Human Immune System mice
人类免疫系统小鼠中 B1 细胞介导的免疫
- 批准号:
8747925 - 财政年份:2014
- 资助金额:
$ 7.75万 - 项目类别:
Induction of polysaccharide vaccine responses in the young by interleukin-7
白细胞介素7诱导年轻人多糖疫苗反应
- 批准号:
8786494 - 财政年份:2014
- 资助金额:
$ 7.75万 - 项目类别:
Toll-like receptor signaling in the generation of B1b cell memory
B1b 细胞记忆生成中的 Toll 样受体信号传导
- 批准号:
8524050 - 财政年份:2012
- 资助金额:
$ 7.75万 - 项目类别:
B1B lymphocytes generate T cell-independent memory
B1B 淋巴细胞产生不依赖于 T 细胞的记忆
- 批准号:
7261873 - 财政年份:2006
- 资助金额:
$ 7.75万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 7.75万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 7.75万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 7.75万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 7.75万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别: